A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as “extracellular vesicles” (EVs), in body fluids could be a biomarker for identifying types of cancer.
In the study, the scientists successfully measured the shape distributions of EVs derived from liver, breast, and colorectal cancer cells, showing that the shape distributions differ from one another. The findings were recently published in the journal Analytical Chemistry.
Early detection of cancerous tumors in the body is essential for effective treatments. However, it is difficult to detect all types of tumors at an early stage, because detection methods differ among types of cancer, and some of the methods require painful medical procedures. It is thus vital to find methods that are painless and can detect multiple types of cancer.
Extracellular vesicles (EVs) are biological particles with a diameter of about 100 nanometers (nm) that are secreted from various cells and exist in body fluids like blood and urine. Notably, EVs contain biological molecules that carry information about the cells of the secretion sources. In addition, genetic materials contained in EVs are involved in communications among cells. This suggests that analyzing biological molecules in EVs present in body fluids could help to detect and identify some kinds of cancerous tumors in the body.
Previous studies had observed images of various shapes of EVs with electron microscopes. However, no technology existed to investigate the shapes of EVs distributed in body fluids, mainly because of difficulties in measuring the shape of nanomaterials in solution. In this context, a team of researchers from Kyushu University, Nagoya University, Osaka University, and Tokyo Medical University tried to investigate the shape of individual EVs in a fluid using a device that they had developed, which can analyze the shape of single particles in solution by measuring the change of ionic current flowing through pores of 200 nm in diameter when particles pass through there.
Using the device, the team successfully measured the shape of EVs derived from cultured liver, breast, and colon cancer cells, as well as from cultured normal breast cells, and found that their shape distributions differ from each other. For example, EVs derived from liver cancer cells include a mix of spherical particles and oval (like rugby balls) particles, whereas EVs from breast cancer cells consist solely of spherical particles.
There is no proof that spike proteins created in response to mRNA vaccines are harmful to the body, scientists have told Reuters. The claim was made by immunologist Byram Bridle (here) in an interview [...]
Scientists have worked out how to best get DNA to communicate with membranes in our body, paving the way for the creation of ‘mini biological computers’ in droplets that have potential uses in biosensing [...]
Reactive oxygen species (ROS) exhibit the potential to act as signal carriers during the development of malignant tumors. At a suitable concentration, ROS tends to mediate cell growth and signal transduction. But ROS are [...]
One of the biggest challenges when it comes to probing and manipulating the brain are the blunt tools we have at our disposal. But breakthroughs in nanotechnology could soon change that, say researchers. Neuroscience has [...]
When liquid meets gas, a unique zone forms. Variable by nature, molecules can cross from one state to another, combining in unique ways to either desirable or unwanted ends. From heat escaping a mug [...]
A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta. According to a briefing from the UK Health Security Agency, released on Friday, [...]
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 variants in serum. Their technique provides a new tool [...]
Lawrence Livermore National Laboratory (LLNL) scientists have developed a new method for 3D printing living microbes in controlled patterns, expanding the potential for using engineered bacteria to recover rare-earth metals, clean wastewater, detect uranium, [...]
Nanomedicines may offer clinicians a way to deliver precise, targeted therapy directly to tumors without damaging surrounding tissue. Yet, progress in the development of new drugs that treat cancer at the nanoparticle level has [...]
Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T [...]
Sunday, October 3, set records for the most COVID-19 deaths in Russia on a single day. Only 29% of people in Russia are vaccinated, despite the country being the first to approve a vaccine. [...]
New research from the University of Technology Sydney (UTS) has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can [...]
New variants of SARS-CoV-2 are more virulent and transmissible than the original variant of the virus. Health experts associate these variants of concern (VOCs) with increased risk of hospitalization, intensive care unit (ICU) admission, [...]
Freeze-dried genetic circuits could reveal the presence of SARS-CoV-2, Ebola, MRSA, and more. Masks and testing have been key to the COVID-19 pandemic response—and now devices that combine the two may be on the [...]